Karbinal™ ER (carbinoxamine maleate) Extended-release Oral Suspension provides
symptomatic relief of seasonal and perennial allergic rhinitis in children at least 2 years of age.
Use of Karbinal ER may result in decreased mental alertness with impaired mental or physical abilities.
The most frequent side effects include:
Ask your doctor or pharmacist for more information.
Call your doctor for medical advice about side effects.
You may report side effects to FDA at 1-800-FDA-1088.
For additional safety information, click here for Full Prescribing Information and discuss with your healthcare provider.
Keep Karbinal ER and all medicines out of the reach of children.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.